Oates-WhiteheadRMBaumerJHHainesL, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2003;2003(4):CD004000. doi:10.1002/14651858.CD004000.
2.
McCrindleBWRowleyAHNewburgerJW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circul-ation. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484.
3.
MahmoudSEl-KallinyMKotbyAEl-GanzouryMFoudaEIbrahimH. Treatment of MIS-C in children and adolescents. Curr Pediatr Rep. 2022;10(1):1-10. doi:10.1007/s40124-021-00259-4.
4.
GaleottiCKaveriSVBayryJ. IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol. 2017;29(11):491-498. doi:10.1093/intimm/dxx039.
5.
StiehmER. Adverse effects of human immunoglobulin therapy. Transfus Med Rev. 2013;27(3):171-178. doi:10.1016/j.tmrv.2013.05.004.
6.
MalletML. Pathophysiology of accidental hypothermia. QJM. 2002;95(12):775-785. doi:10.1093/qjmed/95.12.775.
7.
DuhemCRiesFDicatoM. Intravenous immune globulins and hypothermia. Am J Hematol. 1996;51(2):172-173. doi:10.1002/1096-8652(199602)51:2<172::AID-AJH2830510202>3.0.CO;2-L.
8.
PalabricaFRKwongSLPaduaFR. Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective study. Asia Pac Allergy. 2013;3(4):249-256. doi:10.5415/apallergy.2013.3.4.249.
EdwardsIRAronsonJK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-1259. doi:10.1016/S0140-6736(00)02799-9.
12.
RawlsSMCowanATallaridaRJGellerEBAdlerMW. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i, j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia. J Pharmacol Exp Ther. 2002;303(1):395-402. doi:10.1124/jpet.102.037473.
13.
MellerEHizamiRKreuterL. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors. Pharmacol Biochem Behav. 1989;32(1):141-145.
14.
AdlerMWGellerEBRosowCECochinJ. The opioid system and temperature regulation. Annu Rev Pharmacol Toxicol. 1988;28:429-449. doi:10.1146/annurev.pa.28.040188.002241.
15.
SihlerKCNapolitanoLM. Complications of massive transfusion. Chest. 2010;137(1):209-220. doi:10.1378/chest.09-0252.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
